These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9306059)
1. Matrix metalloproteinases 2 and 9 in equine synovial fluids. Clegg PD; Coughlan AR; Riggs CM; Carter SD Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids. Arican M; Coughlan AR; Clegg PD; Carter SD J Vet Med A Physiol Pathol Clin Med; 2000 Oct; 47(8):449-56. PubMed ID: 11075535 [TBL] [Abstract][Full Text] [Related]
3. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays. Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467 [TBL] [Abstract][Full Text] [Related]
4. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources. Clegg PD; Coughlan AR; Carter SD Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100 [TBL] [Abstract][Full Text] [Related]
5. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids. Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 and -9 are activated in joint diseases. Clegg PD; Carter SD Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092 [TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746 [TBL] [Abstract][Full Text] [Related]
8. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Coughlan AR; Robertson DH; Bennett D; May C; Beynon RJ; Carter SD Vet Rec; 1998 Aug; 143(8):219-23. PubMed ID: 9770764 [TBL] [Abstract][Full Text] [Related]
10. A study of metalloproteinases in fifty joint fluid specimens. Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609 [TBL] [Abstract][Full Text] [Related]
11. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058 [TBL] [Abstract][Full Text] [Related]
12. The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9. Clegg PD; Jones MD; Carter SD J Vet Pharmacol Ther; 1998 Oct; 21(5):406-13. PubMed ID: 9811443 [TBL] [Abstract][Full Text] [Related]
13. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615 [TBL] [Abstract][Full Text] [Related]
14. Cartilage-derived retinoic acid-sensitive protein in equine synovial fluid from healthy and diseased joints. Berg LC; Lenz J; Kjelgaard-Hansen M; Thomsen PD; Jacobsen S Equine Vet J; 2008 Sep; 40(6):553-7. PubMed ID: 18267886 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
16. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis. Brama PA; van den Boom R; DeGroott J; Kiers GH; van Weeren PR Equine Vet J; 2004 Jan; 36(1):34-40. PubMed ID: 14756369 [TBL] [Abstract][Full Text] [Related]
17. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Makowski GS; Ramsby ML Clin Chim Acta; 2003 Mar; 329(1-2):77-81. PubMed ID: 12589968 [TBL] [Abstract][Full Text] [Related]
18. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints. Skiƶldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774 [TBL] [Abstract][Full Text] [Related]
19. Proteolytic enzymes in equine joints with infectious arthritis. Spiers S; May SA; Harrison LJ; Bennett D; Edwards GB Equine Vet J; 1994 Jan; 26(1):48-50. PubMed ID: 8143664 [TBL] [Abstract][Full Text] [Related]
20. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. Kubota E; Kubota T; Matsumoto J; Shibata T; Murakami KI J Oral Maxillofac Surg; 1998 Feb; 56(2):192-8. PubMed ID: 9461144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]